十二指肠乳头肿瘤患者的临床特征分析及其对肿瘤进展期的诊断价值

doi:10.3969/j.issn.1006-7795.2023.06.014

首都医科大学学报 ›› 2023, Vol. 44 ›› Issue (6): 990-998.doi: 10.3969/j.issn.1006-7795.2023.06.014

• 消化系统疾病诊疗技术与进展 • 上一篇下一篇

十二指肠乳头肿瘤患者的临床特征分析及其对肿瘤进展期的诊断价值

乔新伟^#，邱煜婷^#，李鹏，吴静^*，张澍田

首都医科大学附属北京友谊医院消化内科国家消化系统疾病临床医学研究中心，北京 100050

收稿日期:2023-08-15 出版日期:2023-12-21 发布日期:2023-12-20
通讯作者: 吴静 E-mail:wujing36youyi@ccmu.edu.cn
基金资助:
北京市医院管理中心消化内科学科协同发展中心重点项目(XXZ015)，首都临床诊疗技术研究及转化应用项目(Z211100002921028)，首都卫生发展科研专项项目(CFH2022-2-2025)，北京市通州区科技计划项目(KJ2023CX016)。

Analysis of clinical characteristics of patients with duodenal papilla neoplasms and the diagnostic value for advanced carcinoma

Qiao Xinwei^#, Qiu Yuting^#, Li Peng,Wu Jing^*, Zhang Shutian

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing 100050, China

Received:2023-08-15 Online:2023-12-21 Published:2023-12-20
Supported by:
This study was supported by the Digestive Medical Coordinated Development Center of Beijing Hospitals Authority (XXZ015), the Beijing Science and Technology Program (Z211100002921028), the Capital's Funds for Health Improvement and Research (CFH2022-2-2025), Tongzhou Science and Technology Program (KJ2023CX016)。

摘要/Abstract

摘要： 目的本研究旨在探索对鉴别诊断十二指肠乳头肿瘤（duodenal papilla neoplasms，DPNs)早癌与进展期癌有价值的临床指标。方法纳入95例DPNs患者的一般情况、实验室化验以及包括消化内镜等影像学检查的数据，通过LASSO（least absolute shrinkage and selection operator)回归初步筛选预测因素，再通过单因素及多因素Logistic分析确定进展期DPNs的独立危险因素。结果对本研究中的95例DPNs患者，采用LASSO回归筛选出症状、糖类抗原125（carbohydrate antigen 125, CA125)、CA50、γ-谷氨酰基转移酶（γ-glutamyltransferase, GGT)、总胆红素（total bilirubin, TBIL)、血红蛋白（hemoglobin, Hb)等6项指标进行Logistic回归分析，最终确定出现临床症状、GGT以及CA50升高这3项指标是DPNs进入进展期的独立预测因素（P<0.05)。结论出现黄疸等临床症状以及GGT、CA50明显升高可能是比影像学检查更有价值的诊断进展期DPNs的独立危险因素。

关键词: 十二指肠乳头肿瘤, 肿瘤标志物, 进展期癌, 早癌

Abstract: Objective To explore valuable indicators for the differential diagnosis of early and advanced duodenal papilla neoplasms (DPNs).Methods Data of general conditions, laboratory tests and imaging examinations including digestive endoscopy were collected from patients with DPNs. LASSO (least absolute shrinkage and selection operator) regression was used to screen predictive factors. Univariate and multivariate Logistic analysis were used to determine the independent risk factors for advanced DPNs. ResultsA total of 95 DPNs patients were included in this study. Symptoms, carbohydrate antigen 125 （CA125）, CA50, γ-glutamyltransferase （GGT), total bilirubin （TBIL） and hemoglobin （Hb) were screened out by LASSO regression for Logistic regression analysis. Finally, clinical symptoms, elevated GGT and CA50 were validated to be independent predictors of progressive DPNs (P<0.05). Conclusion The clinical symptoms such as jaundice, significantly increased GGT and CA50 are independent risk factors, and it may be more valuable than imaging examination in the judgment of DPNs as advanced carcinoma.

Key words: duodenal papilla neoplasms, biomarker of tumor, advanced stage carcinoma, early-stage carcinoma

中图分类号:

R574

乔新伟, 邱煜婷, 李鹏, 吴静, 张澍田. 十二指肠乳头肿瘤患者的临床特征分析及其对肿瘤进展期的诊断价值[J]. 首都医科大学学报, 2023, 44(6): 990-998.

Qiao Xinwei, Qiu Yuting, Li Peng, Wu Jing, Zhang Shutian. Analysis of clinical characteristics of patients with duodenal papilla neoplasms and the diagnostic value for advanced carcinoma[J]. Journal of Capital Medical University, 2023, 44(6): 990-998.

参考文献

［1］Kleinert R, Prenzel K, Stoecklein N, et al. Gene expression of col11a1 is a marker not only for pancreas carcinoma but also for adenocarcinoma of the papilla of vater, discriminating between carcinoma and chronic pancreatitis［J］. Anticancer Res, 2015, 35(11): 6153-6158.
［2］Meijer L L, Strijker M, de Bakker J K, et al. Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of vater adenocarcinoma［J］. World J Gastrointest Oncol, 2020, 12(3): 347-357.
［3］Nappo G, Gentile D M, Galvanin J, et al. Trans-duodenal ampullectomy for ampullary neoplasms: early and long-term outcomes in 36 consecutive patients［J］. Surg Endosc, 2020, 34(10): 4358-4368.
［4］Lian P L, Chang Y, Xu X C, et al. Pancreaticoduodenectomy for duodenal papilla carcinoma: a single-centre 9-year retrospective study of 112 patients with long-term follow-up［J］. World J Gastroenterol, 2017, 23(30): 5579-5588.
［5］Li S L, Wang Z K, Cai F C, et al. New experience of endoscopic papillectomy for ampullary neoplasms［J］. Surg Endosc, 2019, 33(2): 612-619.
［6］Haraldsson E, Swahn F, Verbeke C, et al. Endoscopic papillectomy and KRAS expression in the treatment of adenoma in the major duodenal papilla［J］. Scand J Gastroenterol, 2015, 50(11): 1419-1427.
［7］Kawashima H, Ohno E, Ishikawa T, et al. Endoscopic papillectomy for ampullary adenoma and early adenocarcinoma: analysis of factors related to treatment outcome and long-term prognosis［J］. Dig Endosc, 2021, 33(5): 858-869.
［8］Panzeri F, Crippa S, Castelli P, et al. Management of ampullary neoplasms: a tailored approach between endoscopy and surgery［J］. World J Gastroenterol, 2015, 21(26): 7970-7987.
［9］Kandler J, Neuhaus H. How to approach a patient with ampullary lesion［J］. Gastroenterology, 2018, 155(6): 1670-1676.
［10］Wei W Y, Mo W X, Wang N, et al. Research and analysis on computed tomography signs and clinical characteristics of chronic duodenal papilla mucositis and duodenal papillary carcinoma［J］. Int J Immunopathol Pharmacol, 2023, 37: 3946320231157868.
［11］Wei X, Chen K, Li D C, et al. Risk and prognostic factors for small bowel adenocarcinoma: a multicenter retrospective observational study in China［J］. Clin Med Insights Oncol, 2022, 16: 11795549221091207.
［12］Wang X J, Ke J L, Xu J X, et al. Radiographic features and clinical factor for preoperative prediction in the bulging duodenal papilla with malignancy［J］. Front Oncol, 2021, 11: 627482.
［13］Jang S Y, Kim J S, Baek S Y, et al. Proposed nomogram predicting neoplastic ampullary obstruction in patients with a suspected ampulla of Vater lesion on CT［J］. Abdom Radiol (NY), 2021, 46(7): 3128-3138.
［14］Gaspar J, Shami V M. The role of EUS in ampullary lesions: is the answer black and white?［J］. Gastrointest Endosc, 2015, 81(2): 389-390.
［15］Ridtitid W, Schmidt S E, Al-Haddad M A, et al. Performance characteristics of EUS for locoregional evaluation of ampullary lesions［J］. Gastrointest Endosc, 2015, 81(2): 380-388.

[1]	乔新伟, 邱煜婷, 李鹏, 吴静, 张澍田. 内镜下十二指肠乳头切除术后短期不良事件危险因素的初步探索[J]. 首都医科大学学报, 2023, 44(6): 982-989.
[2]	何振, 秦达, 李鹏, 朱圣韬, 冀明, 张澍田. 8字环辅助结直肠困难内镜下黏膜剥离术的临床效果评价[J]. 首都医科大学学报, 2023, 44(6): 973-977.
[3]	乔新伟, 邱煜婷, 李鹏, 吴静, 张澍田. 内镜下十二指肠乳头切除术后短期不良事件危险因素的初步探索[J]. 首都医科大学学报, 0, (): 982-989.
[4]	王芸, 李文坤, 苏珈仪, 王亚丹, 吴静. 系统免疫炎症指数在早期结直肠癌及癌前病变筛查中的应用价值[J]. 首都医科大学学报, 2022, 43(5): 760-766.
[5]	马鸣扬, 王洁玮, 李鹏. 细胞内镜评估结直肠病变的研究进展[J]. 首都医科大学学报, 2022, 43(2): 221-226.
[6]	李婕琳, 刘天宇, 张澍田, 隗永秋, 冀明, 李鹏, 王拥军, 吴咏冬. 十二指肠副乳头插管置入胰管支架的安全性评价[J]. 首都医科大学学报, 2022, 43(1): 28-33.
[7]	张兴华, 邢洁, 孙灿, 张希, 王拥军. 溃疡性结肠炎中B细胞对巨噬细胞趋化作用的初步研究[J]. 首都医科大学学报, 2022, 43(1): 42-46.
[8]	邢洁, 任竣瑶, 张倩, 孙秀静, 岳冰, 张一骏, 李荣雪, 朱圣韬, 李鹏, 张澍田. 结直肠腺瘤性息肉发生的危险因素分析[J]. 首都医科大学学报, 2021, 42(4): 601-608.
[9]	吴慧博, 赵海英, 朱圣韬, 吴咏冬, 张澍田. 不同营养素对活动期溃疡性结肠炎患者肠道生物屏障的影响[J]. 首都医科大学学报, 2019, 40(4): 635-639.
[10]	张悦, 李蕴, 张晓丽, 冯小燕, 权竹声, 朱进霞. 帕金森鼠结肠黏膜炎性反应与多巴胺和5-羟色胺受体表达[J]. 首都医科大学学报, 2018, 39(5): 685-692.
[11]	孟莹, 周艳华, 李鹏. 十二指肠胃黏膜异位症的临床特点及内镜诊断[J]. 首都医科大学学报, 2018, 39(5): 721-725.
[12]	轩青霞, 戴发亮, 陈攀, 冯丹丹, 金建军, 高强. NADPH氧化酶NOX1、NOX2和DUOX2在溃疡性结肠炎中的表达分析[J]. 首都医科大学学报, 2017, 38(2): 220-226.
[13]	齐诗蕊, 陈俊, 潘飞, 栾哲, 孙刚. 北京市三级医院小肠疾病诊治现状[J]. 首都医科大学学报, 2017, 38(2): 295-298.
[14]	李艳萍, 李骥, 盖小荣, 吴军, 李文彬, 吴东, 姚方, 李景南. 结直肠息肉发病危险因素分析[J]. 首都医科大学学报, 2013, 34(5): 684-688.
[15]	张莹;孙秀静;朱圣韬. 中国人群中VEGF基因启动子区-460T/C与-634G/C单倍型与结肠癌的易感性研究[J]. 首都医科大学学报, 2012, 33(6): 793-797.

十二指肠乳头肿瘤患者的临床特征分析及其对肿瘤进展期的诊断价值

Analysis of clinical characteristics of patients with duodenal papilla neoplasms and the diagnostic value for advanced carcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价